Guideline for diagnosis, prophylaxis and treatment of invasive fungal infection post burn injury in China 2013

Invasive fungal infection is one of the major complication of severe burns which can induce local or systemic inflammatory response and cause serious substantial damage to the patient. The incidence of fungal infection for burn victims is increasing dramatically during recent years. This guideline, organized by Chinese Society of Burn Surgeons, aims to standardize the diagnosis, prevention and treatment of burn invasive fungal infection. It can be used as one of the tools for treatment of major burn patients.

• Publication year

  2014

• Venue

  Burns & Trauma

• Publication date

  2014-04-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.4103/2321-3868.130182PMID 27602362PMCID 5012031
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Burns, inhalation injury and ventilator-associated pneumonia: Value of routine surveillance cultures

  2013cited by this paper
• High-carbohydrate, high-protein, low-fat versus low-carbohydrate, high-protein, high-fat enteral feeds for burns.

  2012cited by this paper
• Antifungal Prophylaxis and Pre-Emptive Therapy

  2012cited by this paper
• Antimikrobielle Therapie bei Patienten nach Verbrennungstrauma

  2012cited by this paper
• Burns, inhalation injury and ventilator-associated pneumonia: value of routine surveillance cultures.

  2012cited by this paper
• Candidemia and invasive candidiasis: a review of the literature for the burns surgeon.

  2011cited by this paper
• Thermal injury within the first 4 months of life.

  2011cited by this paper
• [Guidelines for specialized nutritional and metabolic support in the critically-ill patient. Update. Consensus of the Spanish Society of Intensive Care Medicine and Coronary Units-Spanish Society of Parenteral and Enteral Nutrition (SEMICYUC-SENPE): critically-burned patient].

  2011cited by this paper
• Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin - review of the literature

  2011cited by this paper
• Candidemia in burn patients: figures and facts.

  2011cited by this paper
• Yeast from burn patients at a major burn centre of China.

  2011cited by this paper
• Recomendaciones para el soporte nutricional y metabólico especializado del paciente crítico. Actualización. Consenso SEMICYUC-SENPE: Paciente quemado crítico

  2011cited by this paper
• IFI = invasive fungal infections. What is that? A misnomer, because a non-invasive fungal infection does not exist!

  2010cited by this paper
• Candida in Burns: Risk Factors and Outcomes

  2010cited by this paper
• Effects of candidaemia on outcome of burns.

  2009cited by this paper
• Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

  2009cited by this paper
• Orbitomaxillary mucormycosis (zygomycosis) and the surgical approach to treatment: perspectives from a maxillofacial surgeon.

  2009cited by this paper
• Differential in vitro activity of anidulafungin, caspofungin and micafungin against Candida parapsilosis isolates recovered from a burn unit.

  2009cited by this paper
• [Retrospective evaluation of the cases with Candida famata fungemia in a burn unit].

  2009cited by this paper
• Emerging Infections in Burns

  2009cited by this paper
• Micafungin for the prophylaxis and treatment of Candida infections

  2008cited by this paper
• Incidence of systemic fungal infection and related mortality following severe burns.

  2008cited by this paper
• Positive Fungal Cultures in Burn Patients: A Multicenter Review

  2008cited by this paper
• Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis.

  2007cited by this paper
• American Burn Association Consensus Conference to Define Sepsis and Infection in Burns

  2007cited by this paper
• Correlation of culture with histopathology in fungal burn wound colonization and infection.

  2007cited by this paper
• Distribution and epidemiology of Candida species causing fungemia at a Saudi Arabian hospital, 1996-2004.

  2007cited by this paper
• Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial.

  2007cited by this paper
• Fungal Wound Infection (Not Colonization) Is Independently Associated With Mortality in Burn Patients

  2007cited by this paper
• Chemical Burn Induced by Cutaneous Exposure to a Concentrated Sodium Hypochlorite and Alkyl Sulfate Solution

  2007cited by this paper
• Anidulafungin versus fluconazole for invasive candidiasis.

  2007cited by this paper
• Micafungin: a new echinocandin.

  2006cited by this paper
• Burn Wound Infections

  2006cited by this paper
• Current approaches to diagnosis and treatment of invasive aspergillosis.

  2006cited by this paper
• Clinical pharmacokinetics of voriconazole.

  2006cited by this paper
• The pathogenesis of burn wound conversion.

  2006cited by this paper
• Preemptive antifungal therapy: still a way to go

  2006cited by this paper
• Open-Label, Randomized Comparison of Itraconazole versus Caspofungin for Prophylaxis in Patients with Hematologic Malignancies

  2006cited by this paper
• Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study.

  2006cited by this paper
• Invasive fungal infections: a review of epidemiology and management options.

  2006cited by this paper
• A microbiologic study of enteral feeding hang time in a burn hospital: can feeding costs be reduced without compromising patient safety?

  2006cited by this paper
• Laboratory diagnosis and therapy of invasive fungal infections.

  2006cited by this paper
• Voriconazole Therapeutic Drug Monitoring

  2006cited by this paper
• Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.

  2005cited by this paper
• Delaying the Empiric Treatment of Candida Bloodstream Infection until Positive Blood Culture Results Are Obtained: a Potential Risk Factor for Hospital Mortality

  2005cited by this paper
• Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial.

  2005cited by this paper
• State of the Art in Burn Treatment

  2005cited by this paper
• Empirical Anti-Candida Therapy among Selected Patients in the Intensive Care Unit: A Cost-Effectiveness Analysis

  2005cited by this paper
• Interactions between bacteria and Candida in the burn wound.

  2005cited by this paper
• Epidemiology and molecular typing of Candida isolates from burn patients

  2004cited by this paper
• The effects of food and dose on the oral systemic availability of itraconazole in healthy subjects

  2004cited by this paper
• Pharmacokinetics of Voriconazole and Cytochrome p450 2C19 Genetic Status

  2004cited by this paper
• Emerging fungal resistance.

  2004cited by this paper
• β-D-glucan as a diagnostic adjunct for invasive fungal infections: Validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome

  2004cited by this paper
• Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome.

  2004cited by this paper
• Caspofungin.

  2003cited by this paper
• Rapid diagnosis of invasive pulmonary aspergillosis by quantitative polymerase chain reaction using bronchial lavage fluid

  2003cited by this paper
• National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003.

  2003cited by this paper
• Diagnosis of invasive mold infection by real-time quantitative PCR.

  2003cited by this paper
• Management of candidiasis Management of Candida species infections in critically ill patients

  2003cited by this paper
• Management of Candida species infections in critically ill patients.

  2003cited by this paper
• A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients.

  2003cited by this paper
• Systemic Candida Infection in Burn Patients: A Case-Control Study of Management Patterns and Outcomes

  2002cited by this paper
• Comparison of caspofungin and amphotericin B for invasive candidiasis.

  2002cited by this paper
• A Clinical Perspective for the Management of Invasive Fungal Infections: Focus on IDSA Guidelines

  2001cited by this paper
• Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia.

  2001cited by this paper
• Evaluation and Survey of Intravenous Vitamin K1 for Treatment of Coagulopathy in Critically Ill Patients

  2001cited by this paper
• Microbiological diagnosis of invasive fungal infections in transplant recipients

  2000cited by this paper
• Nosocomial Candidemia in Non-Neutropenic Patients at an Italian Tertiary Care Hospital

  2000cited by this paper
• Advances in the management of invasive fungal infections in organ transplant recipients: step by step.

  2000cited by this paper
• Advances in the management of invasive fungal infections in organ transplant recipients: step by step

  2000cited by this paper
• Trichosporon beigelii infection: experience in a regional burn center.

  2000cited by this paper
• The reciprocal effect of the causative agents in a mixed infection in burn injury

  1999cited by this paper
• [The reciprocal effect of the causative agents in a mixed infection in burn injury].

  1999cited by this paper
• Correlation between fungi isolated from burn wounds and burn care units.

  1999cited by this paper
• The impact of candidemia on length of hospital stay, outcome, and overall cost of illness.

  1998cited by this paper
• Successful cure of an extensive burn injury complicated with mucor wound sepsis.

  1998cited by this paper
• The role of immunoreconstitution in the management of refractory opportunistic fungal infections.

  1998cited by this paper
• Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery.

  1997cited by this paper
• Effect of a Cola Beverage on the Bioavailability of Itraconazole in the Presence of H2 Blockers

  1997cited by this paper
• State-of-the-art burn treatment.

  1996influential reference
• Microbial colonization of large wounds.

  1995cited by this paper
• Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study.

  1995cited by this paper
• Intravascular catheter exchange and duration of candidemia. NIAID Mycoses Study Group and the Candidemia Study Group.

  1995cited by this paper
• Intravascular Catheter Exchange and Duration of Candidemia

  1995cited by this paper
• [Sepsis by Candida tropicalis in patients with granulocytopenia. A study of 10 cases].

  1994cited by this paper
• Fungal burn wound infection. A 10-year experience.

  1991cited by this paper
• Characterization of Candida isolates from pediatric burn patients

  1988cited by this paper
• Invasive pulmonary aspergillosis in acute leukemia. The contribution of CT to early diagnosis and aggressive management.

  1987cited by this paper
• Fungal infection of the burn wound.

  1979cited by this paper

• Fungal infections in burn patients: The rise of Fusarium as the most prevalent in a burn center in Mexico City

  2025cites this paper
• New Challenges in the Diagnosis and Treatment of Primary Cutaneous Aspergillosis in Extensive Pediatric Burns

  2025cites this paper
• Nutritional interventions in patients with burn injury: an umbrella review of systematic reviews and meta-analyses of randomised clinical trials

  2024cites this paper
• Multi‐state evaluation of Candida infections in burn patients

  2024cites this paper
• Distribution of Nosocomial Pathogens and Antimicrobial Resistance among Patients with Burn Injuries in China: A Comprehensive Research Synopsis and Meta-Analysis

  2024cites this paper
• Clinical impact of fungal colonization of burn wounds in patients hospitalized in the intensive care unit: a retrospective cohort study

  2024cites this paper
• Etiology and Multi-Drug Resistant Profile of Bacterial Infections in Severe Burn Patients, Romania 2018–2022

  2023cites this paper
• Preparation and evaluation of dual drug-loaded nanofiber membranes based on coaxial electrostatic spinning technology.

  2022cites this paper
• Antibacterial silk sericin/poly (vinyl alcohol) hydrogel with antifungal property for potential infected large burn wound healing: Systemic evaluation

  2022cites this paper
• Different Infection Profiles and Antimicrobial Resistance Patterns Between Burn ICU and Common Wards

  2021cites this paper
• Candidemia in pediatric burn patients: Risk factors and outcomes in a retrospective cohort study

  2020cites this paper
• IDENTIFICATION OF PREDISPOSING FACTORS TO MULTIPLE ORGAN DYSFUNCTIONS SYNDROME AMONG BURNED PATIENTS IN INTENSIVE CARE UNIT AT MANSOURA UNIVERSITY

  2020cites this paper
• Fungal Infections in Major Burns - 2 Years Overview

  2020cites this paper
• Evaluation of knowledge and awareness of invasive fungal infections amongst resident doctors in Nigeria

  2020cites this paper
• Infection of burn wound by Aspergillus fumigatus with gross appearance of fungal colonies

  2019cites this paper
• Antifungal agents for invasive candidiasis in non-neutropenic critically-ill adults: what do the guidelines recommend?

  2019cites this paper
• Analysis of multiple organ injury and other related complications , and prognostic factors after burns

  2019cites this paper
• Candidemia in major burn patients and its possible risk factors: A 6-year period retrospective study at a burn ICU.

  2019cites this paper
• Efficacy of Caspofungin in Unclassified Invasive Fungal Infection Cases: A Retrospective Analysis of Patients with Hematological Malignancies in China

  2018cites this paper
• The progress of Chinese burn medicine from the Third Military Medical University—in memory of its pioneer, Professor Li Ao

  2017cites this paper
• High Recovery Rate of Non-albicans Candida Species Isolated From Burn Patients With Candidemia in Iran

  2015cites this paper